Lipid-lowering drugs Flashcards

1
Q

Atherosclerosis can cause

A

CVD as blocks coronary arteries

Intermittent claudication in calf

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Hyperlipidaemia Type I

A

High postprandial chylomicrons
From LPL (or related cofactor) deficiency
Raised TAGs, normal cholesterol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Hyperlipidaemia Type IIa

A

High LDLs
From lack of LDL receptor or mutations
Raised cholesterol, normal TAGs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Hyperlipidaemia Type IIb

A

High VLDL and LDL
From familial combined hyperlipidaemia (genetic)
Raised cholesterol and TAGs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Hyperlipidaemia Type III

A

High IDL
From dysbetalipoproteinaemia, issues with Apo E so IDLs accumulate and some converted to LDL
High cholesterol and TAG

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Hyperlipidaemia Type IV

A

High VLDL
From familial hypertriglyceridaemia (also increased risk of metabolic disease so higher risk of CV event)
Raised TAGs, normal cholesterol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Primary Prevention group (highest risk group factors)

A

Familial hyperlipidaemias
Diabetes
Chronic Kidney Disease
10 yr CV risk >10%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Secondary Prevention (2nd high risk group)

A

All with established CV risk and previous events

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Treatments for lipid lowering

A
Lifestyle changes
Statins (HMG CoA reductase inhibitor)
Ezetimibe
Fibrates
Lomitapide

Not recommended for CV risk reduction:
Bile acid sequestrants, nicotinic acid, Omega-3

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Statins MOA

A

Atorvastatin, simvastatin, pravastatin etc
HMG CoA reductase inhibitor, the rate limiting step in cholesterol synthesis so less synthesis, more LDL receptors expressed on hepatocytes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Ezetimibe MOA

A

Inhibits intestinal cholesterol absorption

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Fibrates MOA

A

bezafibrate, fenofibrate, gemfibrozil etc

Acts as ligand for PPAR-alpha and increases FA oxidation in liver + muscle cells, and activates LPL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

BA sequestrants MOA

A

aka anion exchange resins: colestyramine, colestipol
Bind to + inhibit intestinal BA reabsorption so fats excreted, BA conversion increased so more LDL pulled in from plasma for conversion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Nicotinic acid MOA

A

Reduces VLDL release, plasma triglyceride and cholesterol, and increases HDL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Omega-3

A

Have effect on TAGs and some on cholesterol but no clinical trials showing CVD prevention effectiveness
May be used to treat hypertriglyceridaemia as an adjunct

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Lomitapide MOA + issues

A

Prevents chylomicron + VLDL synthesis

Not much known at the moment as limited studies, also very expensive currently so not used often

17
Q

New possible treatments (+/-)

A

PCSK9 (degrades LDL receptor) inhibitors - monoclonal antibodies proven to be effective
Currently very expensive, multiple injections needed per year so only used in very high risk patients

18
Q

Fibrates uses

A

First line drugs for people with very high plasma triglyceride at risk of pancreatitis as are more effective at reducing than statins

19
Q

Fibrates SE

A

SE: Abdominal effects (nausea, diarrhoea), muscle effects if used in combo with statin

20
Q

Statins not used when

A

Don’t work for homozygous familial hycholesterolaemia as they don’t have LDL receptors
Can’t be given during pregnancy as cholesterol essential for fetal development

21
Q

Lomatipide use

A

Only licensed for patients with homozygous familial hypercholesterolaemia

22
Q

Statins SE

A

SE rare but myopathy occasionally in higher risk, higher dose patients

23
Q

BA sequestrants use

A

Used as an adjunct in hypercholesterolaemia

24
Q

BA sequestrants SE

A

SE: GI disturbance, can cause hypertriglyceridaemia, interferes with fat soluble vitamins

25
Q

Nicotinic acid use

A

Used as adjunct to statin if ever, at lowest dose to avoid SE

26
Q

Nicotinic acid SE

A

SE: prostaglandin mediated flushing, dizziness, palpitations and GI effects, can be reduced with aspirin

27
Q

Ezetimibe use

A

Used mainly as adjunct to statins, or if someone intolerant to statins then helps lower LDLs with little change in HDL cholesterol

28
Q

Ezetimibe SE

A

SE: Steathorrea